Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences (PLSE) posted quarterly Work In Process of $1.8 million for Q2 2022, up 6.68% quarter-over-quarter from $1.7 million in Q1 2022.

Pulse Biosciences (PLSE) Work In Process (2021 - 2022) Analysis & Trends

Pulse Biosciences' Work In Process history runs 2 years deep, the most recent figure standing at $1.8 million for Q2 2022.

In Q2 2022, Work In Process changed N/A year-over-year to $1.8 million; the TTM figure through Jun 2022 stood at $1.8 million (changed N/A YoY), while the FY2021 annual figure was $1.4 million, changed N/A from the prior year.
Work In Process for Q2 2022 stood at $1.8 million, up from $1.7 million in the prior quarter.
The five-year high for Work In Process was $1.8 million in Q2 2022, with the low at $1.2 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Pulse Biosciences	3.33 Bn	3.33 Bn	161,000.00

Download Data